Highlights in Cancer Research: July 2025
The EACR's 'Highlights in Cancer Research' is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the...
Highlights in Cancer Research: March 2025
The EACR's 'Highlights in Cancer Research' is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the...
“It fills a unique gap”: the EACR members who were inspired to create their...
In 2024, we supported 34 EACR members to attend two online training workshops funded by the EACR and facilitated by EMBO. In this article,...
Highlights in Cancer Research: December 2024
The EACR's 'Highlights in Cancer Research' is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the...
Be Curious like a Child; Be Ready as a Pro – Winner of the...
This summer, we invited cancer researchers at all levels to write a blog post for the fourth EACR Science Communication Prize around the theme...
A novel pan-lysyl oxidase inhibitor for improving the treatment of pancreatic cancer: Episode 16...
Dr Jessica Chitty and Dr Thomas Cox generated and validated a novel selective and irreversible pan-lysyl oxidase inhibitor: PXS-5505. Their experiments in a series...
Highlights in Cancer Research: September 2024
The EACR's 'Highlights in Cancer Research' is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the...
“Our grandmothers would be so proud”: unexpected family reunion at the EACR 2024 Congress
At the EACR 2024 Congress in Rotterdam, a chance encounter turned into a heartwarming family reunion for two researchers who had not seen each...
‘Keep Research Curious’: the EACR Science Communication Prize 2024
Have you ever written a blog, or wanted to? This is your chance! Enter an article for #KeepResearchCurious: the EACR Science Communication Prize 2024....
From yeasts and frogs to humans: A tale of battling cancer by understanding cell...
We're campaigning to #KeepResearchCurious: highlighting the importance of curiosity-driven cancer research.
In this series of articles we highlight how fundamental research driven by curiosity can...
More articles
Researchers of Fluidigm: Noel de Miranda’s Immunogenomics Group
There are possibilities and limitations to any cancer treatment, where the expectation of a favorable outcome might only hold true for a subset of...
